Physician profile
Xingyi Que
NPI 1972694388
$5,635.35
in general payments reported to CMS, 2019-2025
25 companies · $313 in 2025
The $313 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,238 · 2020: $267 · 2021: $107 · 2022: $567 · 2023: $1,239 · 2024: $904 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,455.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,840.70 | 2019-2020 | |
| Medtronic, INC. | $956.97 | 2021-2025 | Corevalve Evolut R, Simulus, Penditure |
| Atricure, INC. | $761.17 | 2019-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System, Synergy Ablation System |
| Edwards Lifesciences Corporation | $480.50 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $269.89 | 2020-2023 | Impella |
| Inari Medical, INC. | $172.08 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Intuitive Surgical, INC. | $152.93 | 2021-2023 | Da Vinci Surgical System |
| Phathom Pharmaceuticals, INC. | $116.02 | 2024 | Voquezna |
| Cas Medical Systems INC. | $111.56 | 2019 | |
| Livanova USA, INC. | $105.49 | 2019-2021 | |
| Abbott Laboratories | $97.00 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.15 | 2019 | |
| Boston Scientific Corporation | $76.80 | 2019 | |
| Haemonetics Corporation | $72.21 | 2024 | Teg6s Hemostasis System |
| Getinge USA Sales, LLC | $55.22 | 2024-2025 | Vasoview Hemopro 2, Cardioroot, Acrobat-I Stabilizer |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $55.13 | 2023 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $44.15 | 2024 | Xarelto |
| Davol INC. | $42.77 | 2020 | |
| Ethicon US, LLC | $25.64 | 2023 | Echelon; Endopath, Surgicel Nu-Knit, Echelon Endopath |
| Merck Sharp & Dohme LLC | $25.00 | 2023 | Bridion |
| Lsi Solutions INC | $19.34 | 2020 | |
| Lemaitre Vascular, INC. | $17.96 | 2023 | Artegraft Vascular Graft |
| Heartflow, INC. | $17.40 | 2024 | |
| Innovation Technologies INC | $16.82 | 2022 | |
| Depuy Synthes Sales INC. | $15.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xingyi Que listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.